Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
319.1 INR | +0.42% | +3.77% | +28.00% |
May. 24 | INDIA STOCKS-Indian shares surrender gains as U.S. rate worries weigh | RE |
May. 24 | Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.00% | 4.56B | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-0.61% | 21.83B | |
-10.84% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited
- Eris Lifesciences to Acquire India Formulation Business of Biocon Biologics for INR12.42 Billion